1-3 of 3
Jay Ma
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

KP104, a Bifunctional C5 Mab-Factor H Fusion Protein, Demonstrates Sustained Long-Term Efficacy and Safety in Complement Inhibitor-Naïve PNH Patients: Updated Results from a Phase 2 Study at 36/38 Weeks of Obd Treatment

Fengkui Zhang, Li Zhang, Chen Yang, Changhe Yue, Jay Ma, Chaomei He, Ping Tsui, Qing Yu Christina Weng, Helen Fu, Hui Yan, Wenru Song, Bing Han
Journal: Blood
Blood (2024) 144 (Supplement 1): 2699.
https://doi.org/10.1182/blood-2024-210086
Published: 2024
Journal Articles

KP104, a Bifunctional C5 Antibody/Factor H Fusion Protein, Effectively Controls Both Intravascular and Extravascular Hemolysis: Interim Results from a Phase 2 Study in Complement Inhibitor-Naïve PNH Patients

Fengkui Zhang, Li Zhang, Chen Yang, Chunrong Wang, Changhe Yue, Hui Yan, Jay Ma, Helen Fu, Chaomei He, Ping Tsui, Jingtao Wu, Richard Lee, Wenru Song, Bing Han
Journal: Blood
Blood (2023) 142 (Supplement 1): 572.
https://doi.org/10.1182/blood-2023-186453
Published: 2023
Journal Articles

Trial in Progress: An Open-Label, Phase 2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of KP104 in Complement Inhibitor-Naïve Subjects with Paroxysmal Nocturnal Hemoglobinuria

Fengkui Zhang, Bing Han, Guangsheng He, Hu Zhou, Chunrong Wang, Changhe Yue, Jay Ma, Martin Rabe, Helen Fu, Chaomei He, Ping Tsui, Jingtao Wu, Frederick Beddingfield, Wenru Song, Richard Lee
Journal: Blood
Blood (2022) 140 (Supplement 1): 11459–11460.
https://doi.org/10.1182/blood-2022-159172
Published: 2022